International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
Adapting the implementation of clinical practice guidelines for the screening of infectious diseases and female genital mutilation/cutting in migrants in Spain.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cruz Angeline, Gonçalves Alessandra Queiroga, Vázquez-Villegas José, Vallejo-Godoy Silvia, Álvarez-Ossorio Reyes, Requena Pilar, Martínez-Pérez Ángela, Ferrer Elisabet, Salas-Coronas Joaquín, Luzón-García María Pilar, Cuxart-Graell Alba, Ramirez-Hidalgo Maria F, Muelas-Fernandez Magda, Borjabad Beatriz, Ayats Ardite Josefina, Evangelidou Stella, Aguilar Martín Carina, Requena-Méndez Ana
Аннотация
OBJECTIVES: We aimed to adapt the implementation of vaccination and infectious diseases (IDs) and female genital mutilation/cutting (FGM/C) screening recommendations for migrants in two Spanish primary care settings, Catalonia and Almería.
METHODS: We refined the ADAPTE framework and conducted a literature review of IDs and FGM/C screening and vaccination guidelines (2003-2022) at international, national, and regional levels, two consensus workshops with multidisciplinary teams for recommendations alignment, and a survey to evaluate participants' level of agreement.
RESULTS: The target migrant population was defined, and HIV, hepatitis B (HBV) and C virus (HCV), active tuberculosis (TB), schistosomiasis, strongyloidiasis, Chagas disease, and FGM/C were included in the screening recommendations. In Almería, syphilis, latent TB, and intestinal parasites were also included. However, vaccination was not included at either study site. Both settings agreed to test migrants from high-endemic countries for HBV (prevalence ≥2%), schistosomiasis, strongyloidiasis, and FGM/C. The Catalonia team agreed to test migrants from high-endemic countries for HIV (prevalence >1%), HCV (prevalence ≥2%), and Chagas disease. In Almería, participants agreed to offer universal testing to all migrants for HIV, HCV, and syphilis, whereas Chagas disease was only offered to childbearing-age women and migrants at risk of immunosupression from endemic countries. Both regions recommended active TB screening for newly arrived migrants (<5 years) from TB-incidence countries with ≥50 cases/100,000 population. Almería added latent TB screening in 16-35-year-old migrants.
CONCLUSIONS: We tailored the implementation of the screening recommendations to the migrant profiles and health care contexts, which can enhance health care provision for migrants.
METHODS: We refined the ADAPTE framework and conducted a literature review of IDs and FGM/C screening and vaccination guidelines (2003-2022) at international, national, and regional levels, two consensus workshops with multidisciplinary teams for recommendations alignment, and a survey to evaluate participants' level of agreement.
RESULTS: The target migrant population was defined, and HIV, hepatitis B (HBV) and C virus (HCV), active tuberculosis (TB), schistosomiasis, strongyloidiasis, Chagas disease, and FGM/C were included in the screening recommendations. In Almería, syphilis, latent TB, and intestinal parasites were also included. However, vaccination was not included at either study site. Both settings agreed to test migrants from high-endemic countries for HBV (prevalence ≥2%), schistosomiasis, strongyloidiasis, and FGM/C. The Catalonia team agreed to test migrants from high-endemic countries for HIV (prevalence >1%), HCV (prevalence ≥2%), and Chagas disease. In Almería, participants agreed to offer universal testing to all migrants for HIV, HCV, and syphilis, whereas Chagas disease was only offered to childbearing-age women and migrants at risk of immunosupression from endemic countries. Both regions recommended active TB screening for newly arrived migrants (<5 years) from TB-incidence countries with ≥50 cases/100,000 population. Almería added latent TB screening in 16-35-year-old migrants.
CONCLUSIONS: We tailored the implementation of the screening recommendations to the migrant profiles and health care contexts, which can enhance health care provision for migrants.